مجله علمی پژوهشی سازمان نظام پزشکی
Volume 38, Issue 4 (2020)                   jmciri 2020, 38(4): 218-224 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Prevalence of Dietary Supplements and Anabolic Steroids among Iranian Elite Athletes: a Systematic Review and Meta-analysis. jmciri 2020; 38 (4) :218-224
URL: http://jmciri.ir/article-1-3037-en.html
Abstract:   (5066 Views)
Background: Dietary supplements and anabolic steroids- frequently used by many athletes- are commercially available products consumed as an addition to the usual diet. The aim of this study was to carry out a meta-analytical and systematic review on all papers conducted on the prevalence of dietary supplements and medication among Iranian elite athletes.
Methods: This study is based on the PRISMA guideline on scientific data banks includes SCOPUS, Google Scholar, Web of Knowledge, PubMed, SID and Magiran. Finally, 13 articles including dietary supplements used by athletes (7 papers) and articles focusing on the consumption of anabolic steroid use (6 papers) were analyzed.
Results: The meta-analytic evaluation revealed a general prevalence of 55% of dietary supplements among athletes. The results of the study indicated that there was a high heterogeneity between studies (coefficient I2 was 99.159, P-value less than 0.001). Also, meta-analytic evaluation showed an overall prevalence of 38.9% of anabolic steroids among athletes. The results of the study indicated that there was a high heterogeneity between the studies (coefficient I2 is 986.96, P-value less than 0.001).
Conclusion: Half of the elite Iranian athletes consume dietary supplements and one third of them use anabolic steroids. It seems that the frequency distribution of supplements’ consumption is influenced by different geographic areas.
Full-Text [PDF 489 kb]   (3533 Downloads)    
Type of Study: Research | Subject: General

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.